文献速递基础与转化研究流行病学与生物统计

糖尿病周围神经病变病理生理与治疗进展

Advances in the pathophysiology and treatment of diabetic peripheral neuropathy.
PubMed 文献 · BMJ · 2026-03-26

糖尿病周围神经病变(DPN)可致感觉丧失、步态障碍、皮肤溃疡甚至截肢和神经痛,并增加死亡率。严格控制高血糖不能充分预防DPN,尤其2型糖尿病患者,亟需更有效治疗。本文综述DPN流行病学、危险因素、病理生理与遗传学、诊断治疗及结局评估与生物标志物进展。

要点

  • DPN致感觉丧失、溃疡、截肢和神经痛,增加死亡风险。
  • 严格控制高血糖不能充分预防DPN,尤其2型糖尿病。
  • 亟需新的有效治疗,临床前转化仍具挑战。

核心结论

  • DPN是常见致残性疾病,现有治疗不足,亟需新方向。

研究设计与样本

  • 综述,覆盖DPN流行病学、危险因素、病理生理与遗传学、诊断治疗及结局评估与生物标志物。

主要发现

  • DPN与感觉丧失、步态障碍、皮肤溃疡致截肢、神经痛相关,并影响情绪和生活质量、增加死亡率。
  • 严格控制高血糖不能充分预防DPN,尤其2型糖尿病患者。
  • 对轴胶质相互作用及高血糖以外代谢紊乱等机制的认识在增长,但临床前转化仍具挑战。

临床怎么用

  • 临床应关注DPN的感觉丧失、步态障碍、溃疡和神经痛等表现及死亡风险。
  • 治疗需兼顾高血糖以外的代谢紊乱等机制,并重视社会健康决定因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic peripheral neuropathy (DPN) is a common, debilitating disorder that results in sensory loss, gait dysfunction, propensity to skin ulceration that can lead to limb amputations, and neuropathic pain. DPN has a negative impact on patients' mood and quality of life and is also associated with increased mortality. Disappointingly, aggressive treatment of hyperglycemia does not adequately prevent DPN, particularly in patients with type 2 diabetes, and new, more effective treatments for DPN are urgently needed. Recent decades have witnessed a growing understanding of the risk factors and molecular mechanisms of DPN, such as the importance of axoglial interactions and metabolic derangements beyond hyperglycemia. Despite expanding knowledge, the translation of preclinical insights to treatments that benefit patients remains challenging. This review will cover DPN epidemiology and risk factors, including social determinants of health, DPN pathophysiology and genetics, currently recommended diagnostic and treatment approaches, and available clinical outcomes assessments and biomarkers. Discussion of each of these topics will emphasize recent advances in the field and focus on the challenges and necessary new directions in DPN research.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Fridman V, Elafros M, Eid S, et al. Advances in the pathophysiology and treatment of diabetic peripheral neuropathy. BMJ. 2026. PMID: 41887652. doi:10.1136/bmj-2024-081217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。